Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

NCT06273020 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke, Acute
Diabetes Mellitus, Type 2
Blood Brain Barrier

Interventions

DRUG: Cerebrolysin
PROCEDURE: Brain-MRI with contrast after 10-14 days of cerebrolysin

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez

Collaborators

[object Object]